Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (SHA:603707)

SHA:603707 Revenue

Nanjing King-Friend Biochemical Pharmaceutical had revenue of 885.22M CNY in the quarter ending March 31, 2025, a decrease of -11.85%. This brings the company's revenue in the last twelve months to 3.80B, up 4.86% year-over-year. In the year 2024, Nanjing King-Friend Biochemical Pharmaceutical had annual revenue of 3.92B, down -0.20%.

• Revenue (ttm): 3.80B
• Revenue Growth: +4.86%
• P/S Ratio: 4.65
• Revenue / Employee: 2.80M
• Employees: 1,360
• Market Cap: 17.71B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.92B	-7.80M	-0.20%
Dec 31, 2023	3.93B	218.67M	5.89%
Dec 31, 2022	3.71B	26.03M	0.71%
Dec 31, 2021	3.69B	771.81M	26.48%
Dec 31, 2020	2.91B	445.21M	18.03%